XBI250117C108000
- 0.02
- 0.000.00%
SPDR S&P Biotech ETF Newsroom
Moderna Remains the Most Shorted Stock Among S&P 500 Healthcare Stocks in the Last Month of 2024
Moderna Analyst Ratings
Natera To Provide Roadmap And Outlook At J.P. Morgan Healthcare Conference
Sarepta, Biogen Drugs With Accelerated Approval Under Fire in FDA Report
SPDR S&P Biotech ETF Options Spot-On: On January 14th, 92,360 Contracts Were Traded, With 927.64K Open Interest
On January 14th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 92,360 options for the day, of which put options accounted for 69.71% of the total
The Momentum Factor ETF Is Coming off a Great 2024 but Still Oversold
10 Health Care Stocks With Whale Alerts In Today's Session
AbbVie Goes Ex Dividend Tomorrow
JMP Securities Reiterates Market Perform on Incyteto Market Perform
Incyte At JPM25: Eyes Transformational 2025 With Multiple Drug Launches And Expanding Pipeline
Needham Reiterates Buy on Sarepta Therapeutics, Maintains $202 Price Target
Sarepta Therapeutics Analyst Ratings
On the first day of the JPM Medical Conference, pharmaceutical giants are announcing new strategies. Could the mergers and acquisitions in Biomedical begin in 2025?
In 2025, the Biomedical mergers and acquisitions will begin.
SPDR S&P Biotech ETF Options Spot-On: On January 13th, 93,959 Contracts Were Traded, With 948.11K Open Interest
On January 13th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 93,959 options for the day, of which put options accounted for 61.69% of the total
12 Health Care Stocks Moving In Monday's Pre-Market Session
Dow, S&P, Nasdaq Ended Trading Mixed Ahead of Inflation and Earnings Figures
Unpacking the Latest Options Trading Trends in Amgen
Stocks Edge Down Ahead Of Key Inflation Reports, Crude Hits 5-Month High, Bitcoin Sinks: What's Driving Markets Monday?
Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge
Peering Into Amgen's Recent Short Interest